For research and education only · Not reviewed by a medical professional · Disclaimer · Contains affiliate links

Peptide encyclopedia/ Dihexa
Illustration for Dihexa

THE PEPSRADAR ENCYCLOPEDIA

Dihexa

Cognition and neuronal signaling models

Research topics · Sources checked 2026-10-04

Read the studies ↓

Dihexa AT A GLANCE

The question behind the molecule.

Read findings and limitations ↓
2 selected publicationsContext mattersA mouse task is not a demonstrated improvement in human memory, independence, or dementia progression.

What is Dihexa?

Dihexa is a peptidomimetic studied in experimental cognition research. The selected publication assessed behavioral and molecular changes in a mouse model associated with Alzheimer’s disease.

Biological role or research focus

Cognition and neuronal signaling models.

A mouse task is not a demonstrated improvement in human memory, independence, or dementia progression.

Role reference: AngIV-Analog Dihexa Rescues Cognitive Impairment and Recovers Memory in the APP/PS1 Mouse via the PI3K/AKT Signaling Pathway. · 2021 ↗

Names you may encounter

Angiotensin IV-derived peptidomimetic

Search terms can include brands, combinations, or historical names. They are not automatic product equivalents.

Class / identity
Experimental angiotensin-IV-derived peptidomimetic
Research focus
Cognition and neuronal signaling models
Featured evidence
Animal study
Source check
October 4, 2026

Source: AngIV-Analog Dihexa Rescues Cognitive Impairment and Recovers Memory in the APP/PS1 Mouse via the PI3K/AKT Signaling Pathway. · 2021 ↗

Biology & proposed mechanism

The investigators examined neuronal and inflammatory measures with PI3K/AKT-related signaling. These model findings do not establish the same effect in human disease.

Source: AngIV-Analog Dihexa Rescues Cognitive Impairment and Recovers Memory in the APP/PS1 Mouse via the PI3K/AKT Signaling Pathway. · 2021 ↗

Research context & identity

The featured evidence concerns APP/PS1 mice. Healthy-human performance enhancement and clinical Alzheimer’s treatment require separate evidence.

Source: AngIV-Analog Dihexa Rescues Cognitive Impairment and Recovers Memory in the APP/PS1 Mouse via the PI3K/AKT Signaling Pathway. · 2021 ↗

What does the evidence show?

Selected published evidence, with the population, findings, and limits kept together. These original summaries draw on publication abstracts; they are not a systematic review.

Animal study · 2021

Dihexa in APP/PS1 mice

What did this publication test, and what did it find?

Population / model
APP/PS1 mice in an experimental neurodegeneration model.
Study design
Animal intervention using water-maze behavior and neuronal, inflammatory, and signaling readouts.
Main finding
The report described improved maze performance and changes in neuronal and inflammation-related measures.
Limits & context
A mouse task is not a demonstrated improvement in human memory, independence, or dementia progression.

Source: AngIV-Analog Dihexa Rescues Cognitive Impairment and Recovers Memory in the APP/PS1 Mouse via the PI3K/AKT Signaling Pathway. · 2021 ↗

Animal laboratory study · 2015

Dihexa · zebrafish hair-cell protection

Was Dihexa examined outside cognition models?

Population / model
Larval zebrafish lateral-line sensory hair cells exposed to aminoglycoside antibiotics.
Study design
Drug-toxicity experiments testing Dihexa protection and inhibition of HGF-related signaling.
Main finding
Dihexa reduced hair-cell damage in the tested model. HGF antagonism and inhibition of downstream pathways reduced the protective response.
How to read it
This supports a model-specific mechanism hypothesis, not a treatment for human hearing loss.
Limits & context
Zebrafish hair cells and acute chemical injury differ from clinical hearing disorders. The study does not establish human cognitive benefit, therapeutic dosing, or long-term safety.

Source: Hepatocyte growth factor mimetic protects lateral line hair cells from aminoglycoside exposure. ↗

Read the original paper for methods, adverse events, funding, and conflicts of interest. Publisher access may require a subscription.

Further reading · 3 additional publication links

Exact-name PubMed search checked 2026-10-04. These records have not been appraised. A name match can include related compounds, combinations, or other formulations; it does not establish safety or benefit.

Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. ↗
Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2026 Jan 1 · Journal Article, Review
Read available full text ↗

The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system. ↗
The Journal of pharmacology and experimental therapeutics · 2014 Nov · Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Retracted Publication
Read available full text ↗

The Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's Disease. ↗
Journal of Alzheimer's disease : JAD · 2015 · Journal Article, Research Support, Non-U.S. Gov't, Review

Repeat this PubMed search ↗
Search additional PubMed records ↗

New editorial updates

Loading approved updates…

New source discoveries

Links appear automatically. Unreviewed discoveries are not verified medical findings.

Loading recent discoveries…

Explore the latest source feed →

Safety & precautions

Safety & what remains unknown

This study cannot define long-term human safety, interactions, or the consequences of changing growth-related signaling.

Source: AngIV-Analog Dihexa Rescues Cognitive Impairment and Recovers Memory in the APP/PS1 Mouse via the PI3K/AKT Signaling Pathway. · 2021 ↗

Evidence boundaries

A mouse task is not a demonstrated improvement in human memory, independence, or dementia progression.

Source: AngIV-Analog Dihexa Rescues Cognitive Impairment and Recovers Memory in the APP/PS1 Mouse via the PI3K/AKT Signaling Pathway. · 2021 ↗

This is not a complete list of contraindications, interactions, or adverse effects. Medicine labels apply to specific products and indications; research-use listings are not interchangeable with approved medicines.

What are people discussing?

No editorial transcript note has been reviewed for this profile yet. Below are the matching video records available for exploration; title and caption matches are not verified claims.

Watch the source discussions

5 matching video records · 0 with captions indexed.

Across the full library, 30 caption files are indexed from 20,199 inventoried videos. Most transcripts remain unreviewed. Select a thumbnail or timestamp to watch inside PepsRadar. Thumbnail images load from YouTube.

Sources & supplier listings

Listings are grouped by the vendor’s stated identity. Blends and modified derivatives are labeled separately. Inclusion is not a quality assessment or an endorsement.

Named compound

DIHEXA (5 mg)

American Peptides · Vendor-labeled research use only

$140.00

Listed in stock · Snapshot 2026-10-05
Options may vary. Shipping and tax excluded.

View seller listing ↗

Affiliate link · PepsRadar may earn a commission from purchases through this link. Affiliate disclosure.

Catalog checked 2026-10-04. Seller listings retain their stated intended use. Shops covered: BioLongevity Labs, BioLongevity Supplements, American Peptides, PSPeptides. This is not a market-wide comparison. Affiliate participation does not determine evidence or editorial coverage.

Questions worth asking

  • Does better mouse maze performance prove a dementia treatment?
  • What material, population, and route were actually studied?
  • A mouse task is not a demonstrated improvement in human memory, independence, or dementia progression.
  • What adverse effects, uncertainty, and conflicts of interest does the original source report?

Frequently asked questions

Does better mouse maze performance prove a dementia treatment?

No. Clinical benefit requires trials measuring outcomes in people with the relevant condition.

Source: AngIV-Analog Dihexa Rescues Cognitive Impairment and Recovers Memory in the APP/PS1 Mouse via the PI3K/AKT Signaling Pathway. · 2021 ↗

Does the publication verify a supplier’s product?

No. The tested material and a commercial listing need separate identity and batch checks. A research-use disclaimer does not establish clinical suitability.

Source: AngIV-Analog Dihexa Rescues Cognitive Impairment and Recovers Memory in the APP/PS1 Mouse via the PI3K/AKT Signaling Pathway. · 2021 ↗

References & editorial record

Source notes checked 2026-10-04. Original PepsRadar summaries. Not reviewed by a medical professional. Topic grouping is editorial navigation, not a treatment recommendation. Video notes specify which excerpts were reviewed; no full transcripts are published.

For research and education only. This page does not provide medical advice, diagnosis, or treatment. Research-only listings are not instructions for human use.

WATCH ON PEPSRADAR

Watch video